3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
Frontiers | Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management - Rajkumar - 2018 - American Journal of Hematology - Wiley Online Library
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study - ScienceDirect
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
The DVD Regimen After Myeloma Progression
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Multiple myeloma current treatment algorithms. - Abstract - Europe PMC
Quick Reference Guide - MRSA Topical Eradication
Addition of daratumumab to multiple myeloma backbone regimens significantly improves clinical outcomes: a systematic review and meta-analysis of randomised controlled trials | Scientific Reports
DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Treatment of relapsed and refractory multiple myeloma | Haematologica
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
SYNOPSIS
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Multiple myeloma current treatment algorithms | Blood Cancer Journal
